Glyxambi
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 2553
  • Home
  • Print this page
  • Email this page

    Article Cited by others

LETTER TO EDITOR

Role of intravitreal triamcinolone as an adjuvant in the management of Vogt-Koyanagi-Harada disease

Moreker Mayur R, Lodhi Sikander A, Pathengay Avinash

Year : 2007| Volume: 55| Issue : 6 | Page no: 479-480

   This article has been cited by
 
1 Think Global ? Act Local: Intravitreal Drug Delivery Systems in Chronic Noninfectious Uveitis
Dicle Hazirolan,Uwe Pleyer
Ophthalmic Research. 2013; 49(2): 59
[Pubmed]  [Google Scholar] [DOI]
2 Vogt-Koyanagi-Harada Disease in the Developing World :
Luz Elena Concha del Río, Lourdes Arellanes-García
International Ophthalmology Clinics. 2010; 50(2): 189-199
[Pubmed]  [Google Scholar] [DOI]
3 Intravitreal triamcinolone for intraocular inflammation and associated macular edema
Couch, S.M. and Bakri, S.J.
Clinical Ophthalmology. 2009; 3: 41-47
[Pubmed]  [Google Scholar]

 

Read this article